{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:50:00Z","timestamp":1791575400495,"version":"4.3.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The remnant cholesterol inflammation index (RCII) is a novel biomarker integrating remnant cholesterol and high-sensitivity C-reactive protein. Whether long-term exposure to RCII is associated with diabetes mellitus (DM) remains unclear. We examined the association between cumulative RCII (cumRCII) exposure and incident DM risk in the China Health and Retirement Longitudinal Study. We included 5817 participants with DM at baseline from the China Health and Retirement Longitudinal Study 2011 to 2015. Logistic regression models and restricted cubic splines were used to examine the relationship between cumRCII and DM risk, adjusting for potential confounding factors. Subgroup analysis was used to examine potential effect modification, and sensitivity analysis was used to test the robustness of the primary findings. A total of 786 new-onset DM cases occurred. Participants in the highest quartile of cumRCII levels had a higher DM risk than those in the lowest quartile (odds ratio\u2005=\u20052.47; 95% confidence interval\u2005=\u20051.95\u20133.12;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>trend<\/jats:sub>\n                      \u2005&lt;\u2005.001). Each 1-SD increment in cumRCII was associated with a 25% increased risk (odds ratio\u2005=\u20051.25; 95% confidence interval\u2005=\u20051.18\u20131.33). Restricted cubic spline analysis indicated a positive and nonlinear association between cumRCII and DM (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>for overall<\/jats:sub>\n                      \u2005&lt;\u2005.001;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>for nonlinearity<\/jats:sub>\n                      \u2005&lt;\u2005.001). Subgroup analysis revealed consistent associations between cumRCII and DM risk (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>for interaction<\/jats:sub>\n                      \u2005&gt;\u2005.05).\n                      <jats:italic toggle=\"yes\">E<\/jats:italic>\n                      -value analysis suggested robustness to unmeasured confounding. Elevated long-term cumRCII is significantly associated with higher DM risk in middle-aged and elderly Chinese adults, suggesting that cumRCII may serve as a potential biomarker for identifying individuals at higher metabolic risk.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051063","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:00:23Z","timestamp":1791572423000},"page":"e51063","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cumulative exposure to the remnant cholesterol inflammation index and incident diabetes mellitus in middle-aged and elderly Chinese adults"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-6974","authenticated-orcid":false,"given":"Lianguang","family":"Xie","sequence":"first","affiliation":[{"name":"Liuzhou Traditional Chinese Medical Hospital, Liuzhou, Guangxi, China"},{"name":"Department of Public Health, School of Medicine, Guangxi University of Science and Technology, Liuzhou, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4431-5172","authenticated-orcid":false,"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Public Health, School of Medicine, Guangxi University of Science and Technology, Liuzhou, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yao","sequence":"additional","affiliation":[{"name":"Guangxi University of Chinese Medicine, Nanning, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3512-3764","authenticated-orcid":false,"given":"Diankui","family":"Shui","sequence":"additional","affiliation":[{"name":"Liuzhou Traditional Chinese Medical Hospital, Liuzhou, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013-2018.","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"e1089","DOI":"10.1016\/S2468-2667(24)00250-0","article-title":"Diabetes in China part 1: epidemiology and risk factors.","volume":"9","author":"Xu","year":"2024","journal-title":"Lancet Public Health"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","article-title":"Global burden of metabolic diseases, 1990-2021.","volume":"160","author":"Zhang","year":"2024","journal-title":"Metabolism"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"e70014","DOI":"10.1111\/1753-0407.70014","article-title":"Overview of oxidative stress and inflammation in diabetes.","volume":"16","author":"Weinberg Sibony","year":"2024","journal-title":"J Diabetes"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/cells13191662","article-title":"Inflammatory trajectory of type 2 diabetes: novel opportunities for early and late treatment.","volume":"13","author":"Pellegrini","year":"2024","journal-title":"Cells"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"1336402","DOI":"10.3389\/fendo.2024.1336402","article-title":"Lipid metabolism disorder in diabetic kidney disease.","volume":"15","author":"Han","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"e070284","DOI":"10.1136\/bmjopen-2022-070284","article-title":"Association of C-reactive protein with future development of diabetes: a population-based 7-year cohort study among Norwegian adults aged 30 and older in the Troms\u00f8 Study 2007-2016.","volume":"13","author":"Tong","year":"2023","journal-title":"BMJ Open"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"885516","DOI":"10.3389\/fendo.2022.885516","article-title":"Association between high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes mellitus.","volume":"13","author":"Tang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"e003197","DOI":"10.1136\/bmjdrc-2022-003197","article-title":"Association of high-sensitivity C-reactive protein and diabetic nephropathy in patients with type 2 diabetes: a Mendelian randomization study.","volume":"11","author":"Lin","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"568751","DOI":"10.2147\/DMSO.S568751","article-title":"Promising biomarkers for early diagnosis: advances in understanding the pathogenesis of diabetic peripheral neuropathy.","volume":"19","author":"Lyu","year":"2026","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"e14477","DOI":"10.1111\/cns.14477","article-title":"How inflammation dictates diabetic peripheral neuropathy: an enlightening review.","volume":"30","author":"Cheng","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12933-022-01554-0","article-title":"The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus.","volume":"21","author":"Hu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/eurheartj\/ehac783","article-title":"What is \u2018remnant cholesterol\u2019?","volume":"44","author":"St\u00fcrzebecher","year":"2023","journal-title":"Eur Heart J"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/joim.13298","article-title":"Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes.","volume":"290","author":"Jansson Sigfrids","year":"2021","journal-title":"J Intern Med"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"117508","DOI":"10.1016\/j.atherosclerosis.2024.117508","article-title":"Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes.","volume":"395","author":"Vargas-V\u00e1zquez","year":"2024","journal-title":"Atherosclerosis"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/STROKEAHA.121.037756","article-title":"Remnant cholesterol variability and incident ischemic stroke in the general population.","volume":"53","author":"Li","year":"2022","journal-title":"Stroke"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12888-023-04770-4","article-title":"Association of remnant cholesterol with depression among US adults.","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00592-024-02416-9","article-title":"Association of remnant cholesterol with progression and regression of prediabetes in middle-aged and older adults: a nationwide cohort study.","volume":"62","author":"Jiang","year":"2025","journal-title":"Acta Diabetol"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jacl.2023.01.007","article-title":"The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).","volume":"17","author":"Cesena","year":"2023","journal-title":"J Clin Lipidol"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.jacc.2021.04.059","article-title":"Triglycerides and residual atherosclerotic risk.","volume":"77","author":"Raposeiras-Roubin","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R22-20261009","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2018.294926","article-title":"Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population.","volume":"65","author":"Hansen","year":"2019","journal-title":"Clin Chem"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.2147\/JIR.S435398","article-title":"The systemic inflammation index predicts poor clinical prognosis in patients with initially diagnosed acute coronary syndrome undergoing primary coronary angiography.","volume":"16","author":"Gao","year":"2023","journal-title":"J Inflamm Res"},{"key":"R24-20261009","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4093\/dmj.2025.0305","article-title":"Association of remnant cholesterol inflammation index with cardiovascular risks and all-cause mortality in individuals with diabetes or prediabetes.","volume":"50","author":"Ma","year":"2026","journal-title":"Diabetes Metab J"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12944-025-02580-z","article-title":"Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese national population surveys.","volume":"24","author":"Wang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-025-02650-2","article-title":"Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National Institutes of Health Stroke Scale and modified Rankin scale.","volume":"24","author":"Yu","year":"2025","journal-title":"Lipids Health Dis"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jare.2024.12.015","article-title":"Predictive value of remnant cholesterol inflammatory index for stroke risk: evidence from the China Health and Retirement Longitudinal Study.","volume":"76","author":"Chen","year":"2025","journal-title":"J Adv Res"},{"key":"R28-20261009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS).","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R29-20261009","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/aje\/kwz170","article-title":"Venous blood-based biomarkers in the China Health and Retirement Longitudinal Study: rationale, design, and results from the 2015 Wave.","volume":"188","author":"Chen","year":"2019","journal-title":"Am J Epidemiol"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"R31-20261009","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the E-value to assess the potential effect of unmeasured confounding in observational studies.","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1111\/dom.16383","article-title":"Changes in remnant cholesterol and the incidence of diabetes: results from two large prospective cohort studies.","volume":"27","author":"Shao","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"R33-20261009","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12944-024-02393-6","article-title":"Association of remnant cholesterol with insulin resistance and type 2 diabetes: mediation analyses from NHANES 1999-2020.","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"R34-20261009","doi-asserted-by":"crossref","first-page":"e13592","DOI":"10.1111\/1753-0407.13592","article-title":"Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: a multicenter, large sample survey.","volume":"16","author":"Li","year":"2024","journal-title":"J Diabetes"},{"key":"R35-20261009","doi-asserted-by":"crossref","first-page":"24616","DOI":"10.1038\/s41598-024-75951-8","article-title":"Remnant cholesterol elevates hyperuricemia risk in the middle aged and elderly Chinese: a longitudinal study.","volume":"14","author":"Ma","year":"2024","journal-title":"Sci Rep"},{"key":"R36-20261009","doi-asserted-by":"crossref","first-page":"e3446","DOI":"10.1002\/dmrr.3446","article-title":"High-sensitivity C-reactive protein and risk of type 2 diabetes: a nationwide cohort study and updated meta-analysis.","volume":"37","author":"Yang","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"R37-20261009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.diabres.2017.04.012","article-title":"Plasma ferritin, C-reactive protein, and risk of incident type 2 diabetes in Singapore Chinese men and women.","volume":"128","author":"Wang","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"R38-20261009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12933-019-0913-2","article-title":"Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study.","volume":"18","author":"Yan","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"R39-20261009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12967-025-07544-6","article-title":"Effects of combined high-sensitivity C-reactive protein and residual cholesterol levels on new-onset diabetes: evidence from two prospective cohort studies.","volume":"24","author":"Shao","year":"2025","journal-title":"J Transl Med"},{"key":"R40-20261009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12933-025-02869-4","article-title":"Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study.","volume":"24","author":"Ma","year":"2025","journal-title":"Cardiovasc Diabetol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:00:29Z","timestamp":1791572429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051063"}},"subtitle":["A nationwide cohort study from CHARLS"],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":39,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051063","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"2026-04-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}